A pair of studies show that Zepbound can help adults with obesity and overweight achieve sustained and meaningful weight loss ...

Tirzapetide dose escalation schedules were slower in the real-world than clinical settings among individuals with obesity without T2D.

By December 2023, 12.3% of all glucose-lowering medication dispensations were tirzepatide among adults with T2DM.

A new study has found that the weight-loss drug tirzepatide can help people lose a significant amount of weight and keep it ...

Once-weekly treatment with tirzepatide can produce clinically meaningful and sustained weight loss for at least three years ...